
A retrospective study finds that direct selective laser trabeculoplasty significantly lowers intraocular pressure, with the greatest benefit seen in treatment-naive eyes.
Boston-Selective laser trabeculoplasty (SLT) could potentially be used as a first-line therapy for primary open-angle glaucoma (POAG)because it is much less traumatic to the eye than the currently used argon laser trabeculoplasty (ALT), according to its inventor, Mark Latina, MD.




